HIGHLIGHTS
- who: Dalia Zaafar and colleagues from the Pharmacology and Toxicology Department, Faculty of Pharmacy, Modern University for Information and Technology have published the Article: Advances in Animal and Veterinary Sciences The Role of Pioglitazone Against Ehrlich Solid Carcinoma Mice Model Through Antiproliferative and Antiangiogenic Pathways, in the Journal: (JOURNAL)
- what: Methods: This study examined the effectiveness of pioglitazone (Pio) against mice bearing Ehrlich solid carcinoma in terms of its ability to inhibit cell proliferation and angiogenesis. The authors used the ESC model, a form of Furthermore, some pharmaceutical agents` antineoplastic spontaneous murine adenocarcinoma in all . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.